DAY101 In Gliomas and Other Tumors
Condition(s):Low-grade GliomaLast Updated:May 12, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Low-grade GliomaLast Updated:May 12, 2023Active, not recruiting
Condition(s):Low Grade GliomasLast Updated:March 7, 2017Completed
Condition(s):Low-Grade Gliomas; Malignant Neoplasms, Brain; Soft Tissue NeoplasmsLast Updated:October 3, 2023Active, not recruiting
Condition(s):Low Grade GliomaLast Updated:August 19, 2015Completed
Condition(s):Low-grade GliomaLast Updated:January 31, 2024Available
Condition(s):Post Low Grade Glioma Surgery; Cognitive DeficitsLast Updated:April 24, 2014Unknown status
Condition(s):Low Grade Glioma; Neurofibromatosis Type 1; Visual Pathway GliomaLast Updated:March 21, 2024Recruiting
Condition(s):GliomaLast Updated:May 11, 2023Recruiting
Condition(s):Brain Neoplasm; Low Grade Glioma; Seizure DisorderLast Updated:December 8, 2023Recruiting
Condition(s):Low Grade GliomaLast Updated:March 28, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.